Together, these results suggest that TR4 binding at the non-risk allele is linked to transcriptional repression, consistent with previous reports about TR4 activity28, 29, and that TR4 binding and repression is disrupted by the T2D risk allele at rs508419, which results in increased ANK1 expression. The gene discussed is ANK1; the disease is type 2 diabetes mellitus.